The WACC of Denali Therapeutics Inc (DNLI) is 7.7%.
| Range | Selected | |
| Cost of equity | 8.80% - 12.00% | 10.40% |
| Tax rate | 0.10% - 0.20% | 0.15% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.9% - 8.5% | 7.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.07 | 1.27 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.80% | 12.00% |
| Tax rate | 0.10% | 0.20% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.9% | 8.5% |
| Selected WACC | 7.7% | |